Glioma Gene Panel by NGS (SNVs & InDels) near me in New Delhi

The Glioma gene panel is a cutting-edge next-generation sequencing tool designed to potentially offer significant treatment advantages to patients with glioma, a type of brain cancer. This panel meticulously examines 7 pivotal genes associated with glioma, including ATRX, BRAF, TP53, IDH1, IDH2, H3-3A, and TERT, seeking out various single nucleotide variants (SNVs) and insertions/deletions (InDels). With a minimum sequencing depth of 250X on a validated Illumina platform, this panel ensures robust and reliable results. The identified genetic variations are meticulously annotated using an in-house pipeline, and reportable genomic alterations are prioritized and classified in accordance with AMP-ASCO-CAP guidelines, offering invaluable insights for personalized treatment strategies.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.